🔎 Trials Near Me

Utama › Karsinoma Sel Skuamosa Kepala dan Leher › Maryland › Baltimore

Kajian klinikal Karsinoma Sel Skuamosa Kepala dan Leher di Baltimore, MD

15 kajian untuk Karsinoma Sel Skuamosa Kepala dan Leher sedang mencari peserta di lokasi dalam dan sekitar Baltimore (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Mengambil pesertaFasa 2/3
  • Site #0112, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Mengambil pesertaFasa 1
  • Exelixis Clinical Site #14, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Mengambil pesertaFasa 3
  • University of Maryland/Greenebaum Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06589804

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Mengambil pesertaFasa 3
  • University of Maryland Greenebaum Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Mengambil pesertaFasa 1/2
  • University of Maryland School of Medicine, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06385080

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 2
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mi jauh
Umur 18 hingga 79 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04671667

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Mengambil pesertaFasa 2
  • Greater Baltimore Medical Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT02734537

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 2
  • Research Site, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06535607

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Mengambil pesertaKajian pemerhatian
  • University of Maryland, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06163534

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Mengambil pesertaFasa 2
  • Greater Baltimore Medical Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06532279

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Mengambil pesertaFasa 1
  • Johns Hopkins Hospital /ID# 254056, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT04777994

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 3
  • University of Maryland, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06064877

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Mengambil pesertaFasa 1
  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Mengambil pesertaFasa 2
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland Greenebaum Cancer Center, Baltimore
  • Baltimore Washington Medical Center, Glen Burnie · 9 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Nov 2025 · NCT06088381

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Mengambil pesertaFasa 1/2
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Nov 2025 · NCT05902988

Kajian Karsinoma Sel Skuamosa Kepala dan Leher di bandar lain

Kajian lain di Baltimore

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.